Published in Int J Antimicrob Agents on January 22, 2007
Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis. Antimicrob Agents Chemother (2012) 1.33
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases. Sci Rep (2015) 1.03
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance. Curr Cardiol Rev (2009) 0.98
Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis. Int J Chron Obstruct Pulmon Dis (2009) 0.80
Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients. Antimicrob Agents Chemother (2013) 0.78
Levofloxacin-induced torsades de pointes. Tex Heart Inst J (2010) 0.77
Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimicrob Chemother (2007) 2.79
Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect (2009) 2.40
Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis (2008) 2.08
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis (2011) 2.03
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother (2012) 2.01
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother (2007) 1.89
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents (2009) 1.88
Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother (2008) 1.85
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother (2013) 1.85
Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect (2012) 1.84
Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med (2008) 1.69
Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist Updat (2010) 1.66
The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res (2007) 1.65
Worldwide prevalence of head lice. Emerg Infect Dis (2008) 1.58
Research contribution of different world regions in the top 50 biomedical journals (1995-2002). FASEB J (2006) 1.54
Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care (2007) 1.52
Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass. J Thorac Cardiovasc Surg (2006) 1.45
Non-physicians may reach correct diagnoses by using Google: a pilot study. Swiss Med Wkly (2008) 1.40
Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother (2006) 1.39
Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother (2009) 1.38
Tuberculosis of the oral cavity: a systematic review. Eur J Oral Sci (2010) 1.37
Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents (2008) 1.36
Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol (2009) 1.34
Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. Scand J Infect Dis (2005) 1.33
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents (2012) 1.32
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents (2009) 1.23
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin Investig Drugs (2009) 1.19
Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg (2006) 1.17
Pyomyositis associated with hematological malignancy: case report and review of the literature. Int J Infect Dis (2007) 1.09
Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Int J Antimicrob Agents (2010) 1.07
Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis. Int J Infect Dis (2012) 1.05
Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin. J Infect (2005) 1.05
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. Eur J Clin Pharmacol (2010) 1.05
Chronic bacterial and parasitic infections and cancer: a review. J Infect Dev Ctries (2010) 1.03
Clinical decision-making based on findings presented in conference abstracts: is it safe for our patients? Eur Heart J (2006) 1.03
Systemic colistin use in children without cystic fibrosis: a systematic review of the literature. Int J Antimicrob Agents (2009) 1.02
Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother (2010) 0.99
Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Respir Med (2008) 0.95
Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol (2012) 0.93
Do PubMed and Google searches help medical students and young doctors reach the correct diagnosis? A pilot study. Eur J Intern Med (2009) 0.93
Case 38-2013: A man with fever and lymphadenopathy. N Engl J Med (2014) 0.92
Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis. PLoS One (2012) 0.91
Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials. Future Microbiol (2010) 0.91
Increasing contribution of China in modern biomedical research. Statistical data from ISI Web of Knowledge. Med Sci Monit (2009) 0.90
Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression. Int J Antimicrob Agents (2012) 0.90
Bacterial interference for the prevention and treatment of infections. Int J Antimicrob Agents (2008) 0.90
Streptococcus agalactiae infections in non-pregnant adults: single center experience of a growing clinical problem. Med Sci Monit (2006) 0.88
Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother (2010) 0.87
Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Saf (2012) 0.87
Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives. Expert Opin Investig Drugs (2008) 0.86
When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach. Shock (2007) 0.85
Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis. Antimicrob Agents Chemother (2012) 0.85
Nephrotoxicity of colistin: new insight into an old antibiotic. Clin Infect Dis (2009) 0.85
Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital. BMC Infect Dis (2006) 0.84
Frequency of the off-label use of antibiotics in clinical practice: a systematic review. Expert Rev Anti Infect Ther (2012) 0.83
Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype. Cancer Detect Prev (2006) 0.83
Effectiveness and safety of tigecycline: focus on use for approved indications. Clin Infect Dis (2012) 0.82
Seasonality of mortality: the September phenomenon in Mediterranean countries. CMAJ (2009) 0.82
Susceptibility of Gram-negative bacteria to isepamicin: a systematic review. Expert Rev Anti Infect Ther (2012) 0.81
Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials. Curr Med Res Opin (2008) 0.81
Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis. J Antimicrob Chemother (2010) 0.79
Cholestasis in acute stroke: an investigation on its prevalence and etiology. Scand J Gastroenterol (2005) 0.78
Recurrent post-sternotomy mediastinitis. J Infect (2005) 0.78
High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough. Respir Med (2008) 0.77
Peripheral T-cell lymphoma masquerading as infectious cellulitis. Eur J Dermatol (2007) 0.77
Knowledge and practices regarding prevention of infections associated with central venous catheters: a survey of intensive care unit medical and nursing staff. Am J Infect Control (2011) 0.77
Frequency of the off-label use of monoclonal antibodies in clinical practice: a systematic review of the literature. Curr Med Res Opin (2013) 0.76
Do high doses of quinolones decrease the emergence of antibacterial resistance? A systematic review of data from comparative clinical trials. J Infect (2007) 0.76
Colistin in ventilator-associated pneumonia. Clin Infect Dis (2012) 0.75
Open-access Web resources on cardiovascular infections and inflammations. Can J Cardiol (2008) 0.75
Henoch-Schönlein purpura associated with Proteus mirabilis urinary tract infection. J Am Acad Dermatol (2008) 0.75
Pulmonary drug delivery systems for antimicrobial agents: facts and myths. Int J Antimicrob Agents (2009) 0.75
Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence. Int J Antimicrob Agents (2011) 0.75
Evaluation of a direct test for seasonal influenza in outpatients. Eur J Intern Med (2010) 0.75
Matching criteria in case-control studies in the field of antimicrobial resistance. Microb Drug Resist (2008) 0.75
Antimicrobial activity and clinical effectiveness of sisomicin: an evaluation of the literature (1995-2011). Expert Rev Anti Infect Ther (2013) 0.75